TNF and COVID-19: The pooled analysis showed decreased effects on TNF-α between the CHM and control treatment groups among COVID-19 patients, of which, the combined WMD of TNF-α was −3.80 (95% CI, −5.96, −1.65, P = 0.0005; random effect model) (Figure 2G).